Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 70

1.

One-year Outcomes of Prasugrel Versus Ticagrelor In Acute Myocardial Infarction Treated With Primary Angioplasty: The PRAGUE-18 Study.

Motovska Z, Hlinomaz O, Kala P, Hromadka M, Knot J, Varvarovsky I, Dusek J, Jarkovsky J, Miklik R, Rokyta R, Tousek F, Kramarikova P, Svoboda M, Majtan B, Simek S, Branny M, Mrozek J, Cervinka P, Ostransky J, Widimsky P; PRAGUE-18 Study Group.

J Am Coll Cardiol. 2017 Nov 9. pii: S0735-1097(17)41524-5. doi: 10.1016/j.jacc.2017.11.008. [Epub ahead of print]

2.

Cangrelor With and Without Glycoprotein IIb/IIIa Inhibitors in Patients Undergoing Percutaneous Coronary Intervention.

Vaduganathan M, Harrington RA, Stone GW, Deliargyris EN, Steg PG, Gibson CM, Hamm CW, Price MJ, Menozzi A, Prats J, Elkin S, Mahaffey KW, White HD, Bhatt DL; CHAMPION Investigators.

J Am Coll Cardiol. 2017 Jan 17;69(2):176-185. doi: 10.1016/j.jacc.2016.10.055.

PMID:
28081827
3.

Prasugrel Versus Ticagrelor in Patients With Acute Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention: Multicenter Randomized PRAGUE-18 Study.

Motovska Z, Hlinomaz O, Miklik R, Hromadka M, Varvarovsky I, Dusek J, Knot J, Jarkovsky J, Kala P, Rokyta R, Tousek F, Kramarikova P, Majtan B, Simek S, Branny M, Mrozek J, Cervinka P, Ostransky J, Widimsky P; PRAGUE-18 Study Group.

Circulation. 2016 Nov 22;134(21):1603-1612. Epub 2016 Aug 30.

4.

Transcranial Magnetic Stimulation of the Supplementary Motor Area in the Treatment of Obsessive-Compulsive Disorder: A Multi-Site Study.

Hawken ER, Dilkov D, Kaludiev E, Simek S, Zhang F, Milev R.

Int J Mol Sci. 2016 Mar 22;17(3):420. doi: 10.3390/ijms17030420.

5.

Concise Review: The U.S. Food and Drug Administration and Regenerative Medicine.

Witten CM, McFarland RD, Simek SL.

Stem Cells Transl Med. 2015 Dec;4(12):1495-9. doi: 10.5966/sctm.2015-0098. Epub 2015 Oct 22. Review.

6.

Effect of platelet inhibition with cangrelor during PCI on ischemic events.

Bhatt DL, Stone GW, Mahaffey KW, Gibson CM, Steg PG, Hamm CW, Price MJ, Leonardi S, Gallup D, Bramucci E, Radke PW, Widimský P, Tousek F, Tauth J, Spriggs D, McLaurin BT, Angiolillo DJ, Généreux P, Liu T, Prats J, Todd M, Skerjanec S, White HD, Harrington RA; CHAMPION PHOENIX Investigators.

N Engl J Med. 2013 Apr 4;368(14):1303-13. doi: 10.1056/NEJMoa1300815. Epub 2013 Mar 10.

7.

Effects of dalcetrapib in patients with a recent acute coronary syndrome.

Schwartz GG, Olsson AG, Abt M, Ballantyne CM, Barter PJ, Brumm J, Chaitman BR, Holme IM, Kallend D, Leiter LA, Leitersdorf E, McMurray JJ, Mundl H, Nicholls SJ, Shah PK, Tardif JC, Wright RS; dal-OUTCOMES Investigators.

N Engl J Med. 2012 Nov 29;367(22):2089-99. doi: 10.1056/NEJMoa1206797. Epub 2012 Nov 5.

8.

Reduced thrombin generation and soluble P-selectin after intravenous enoxaparin during PCI.

Kvasnička J, Horák J, Zenáhlíková Z, Kvasnička T, Simek S, Kovárník T, Malíková I, Linhart A, Aschermann M.

Cardiovasc Drugs Ther. 2011 Jun;25(3):243-50. doi: 10.1007/s10557-011-6301-0.

PMID:
21584633
9.

Herpes simplex virus-induced cardiomyopathy successfully treated with acyclovir.

Kuchynka P, Palecek T, Hrbackova H, Vitkova I, Simek S, Nemecek E, Aster V, Louch WE, Aschermann M, Linhart A.

Wien Klin Wochenschr. 2010 Oct;122(19-20):592-5. doi: 10.1007/s00508-010-1456-4. Epub 2010 Sep 28.

PMID:
20865454
10.

Platelet gene polymorphisms and risk of bleeding in patients undergoing elective coronary angiography: a genetic substudy of the PRAGUE-8 trial.

Motovska Z, Kvasnicka J, Hajkova J, Kala P, Simek S, Bobcikova P, Petr R, Bilkova D, Poloczek M, Miklik R, Fischerova M, Maly M, Widimsky P.

Atherosclerosis. 2010 Oct;212(2):548-52. doi: 10.1016/j.atherosclerosis.2010.07.006. Epub 2010 Jul 16.

PMID:
20691446
11.

Presence of Borrelia burgdorferi in endomyocardial biopsies in patients with new-onset unexplained dilated cardiomyopathy.

Palecek T, Kuchynka P, Hulinska D, Schramlova J, Hrbackova H, Vitkova I, Simek S, Horak J, Louch WE, Linhart A.

Med Microbiol Immunol. 2010 May;199(2):139-43. doi: 10.1007/s00430-009-0141-6. Epub 2010 Jan 6.

PMID:
20052487
12.

Rationale and design of the dal-OUTCOMES trial: efficacy and safety of dalcetrapib in patients with recent acute coronary syndrome.

Schwartz GG, Olsson AG, Ballantyne CM, Barter PJ, Holme IM, Kallend D, Leiter LA, Leitersdorf E, McMurray JJ, Shah PK, Tardif JC, Chaitman BR, Duttlinger-Maddux R, Mathieson J; dal-OUTCOMES Committees and Investigators.

Am Heart J. 2009 Dec;158(6):896-901.e3. doi: 10.1016/j.ahj.2009.09.017.

PMID:
19958854
13.

Intravenous platelet blockade with cangrelor during PCI.

Bhatt DL, Lincoff AM, Gibson CM, Stone GW, McNulty S, Montalescot G, Kleiman NS, Goodman SG, White HD, Mahaffey KW, Pollack CV Jr, Manoukian SV, Widimsky P, Chew DP, Cura F, Manukov I, Tousek F, Jafar MZ, Arneja J, Skerjanec S, Harrington RA; CHAMPION PLATFORM Investigators.

N Engl J Med. 2009 Dec 10;361(24):2330-41. doi: 10.1056/NEJMoa0908629.

14.

Hemodynamic response to thoracoscopy and thoracotomy.

Trca S, Krska Z, Kittnar O, Mlcek M, Demes R, Danzig V, Simek S, Bruthans J, Frasko R.

Physiol Res. 2010;59(3):363-71. Epub 2009 Aug 12.

15.

High loading dose of clopidogrel is unable to satisfactorily inhibit platelet reactivity in patients with glycoprotein IIIA gene polymorphism: a genetic substudy of PRAGUE-8 trial.

Motovska Z, Widimsky P, Kvasnicka J, Petr R, Bilkova D, Hajkova J, Marinov I, Simek S, Kala P; PRAGUE-8 study investigators.

Blood Coagul Fibrinolysis. 2009 Jun;20(4):257-62.

PMID:
19530321
16.

Factors influencing clopidogrel efficacy in patients with stable coronary artery disease undergoing elective percutaneous coronary intervention: statin's advantage and the smoking "paradox".

Motovska Z, Widimsky P, Petr R, Bilkova D, Marinov I, Simek S, Kala P; PRAGUE-8 Study Investigators.

J Cardiovasc Pharmacol. 2009 May;53(5):368-72. doi: 10.1097/FJC.0b013e31819d616b.

PMID:
19247187
17.

Optimal pretreatment timing for high load dosing (600 mg) of clopidogrel before planned percutaneous coronary intervention for maximal antiplatelet effectiveness.

Motovska Z, Widimsky P, Petr R, Bilkova D, Marinov I, Simek S, Kala P.

Int J Cardiol. 2010 Oct 8;144(2):255-7. doi: 10.1016/j.ijcard.2009.01.017. Epub 2009 Feb 15.

PMID:
19232444
18.

[The isolated form of cardiac amyloidosis in the form of beginning infiltrative cardiomyopathy without restrictive physiology].

Kuchynka P, Palecek T, Simek S, Lubanda JC, Elleder M, Spicka I, Jansa P, Linhart A.

Vnitr Lek. 2008 Oct;54(10):1010-3. Czech.

PMID:
19009770
19.

Are acute effects of maximal dynamic contractions on upper-body ballistic performance load specific?

Markovic G, Simek S, Bradic A.

J Strength Cond Res. 2008 Nov;22(6):1811-5. doi: 10.1519/JSC.0b013e318182227e.

PMID:
18815568
20.

Clopidogrel pre-treatment in stable angina: for all patients > 6 h before elective coronary angiography or only for angiographically selected patients a few minutes before PCI? A randomized multicentre trial PRAGUE-8.

Widimsky P, Motovská Z, Simek S, Kala P, Pudil R, Holm F, Petr R, Bílková D, Skalická H, Kuchynka P, Poloczek M, Miklík R, Maly M, Aschermann M; PRAGUE-8 Trial Investigators.

Eur Heart J. 2008 Jun;29(12):1495-503. doi: 10.1093/eurheartj/ehn169. Epub 2008 Apr 25.

Supplemental Content

Loading ...
Support Center